Start with Meloxicam 7.5 mg Daily for Osteoarthritis
You should start with meloxicam 7.5 mg once daily rather than jumping straight to 15 mg, as this lower dose provides effective pain relief with better gastrointestinal tolerability comparable to placebo, and you can always escalate if needed. 1
The Evidence-Based Rationale
Guideline Framework: Use the Lowest Effective Dose
The NICE guidelines explicitly state to "use oral NSAIDs or COX 2 inhibitors at the lowest effective dose for the shortest possible period of time" when treating osteoarthritis 1. This principle prioritizes minimizing gastrointestinal, liver, and cardiorenal toxicity while maintaining analgesic efficacy—directly impacting morbidity and mortality.
Both Doses Work, But 7.5 mg Is Safer
Multiple randomized controlled trials demonstrate that:
- Meloxicam 7.5 mg is significantly more effective than placebo for pain on movement (p < 0.01) and shows favorable global efficacy (p < 0.05) 2
- Both 7.5 mg and 15 mg doses have similar analgesic magnitude to other NSAIDs, but vary in their toxicity profiles 1
- The 7.5 mg dose causes less total GI toxicity (dyspepsia, abdominal pain, nausea, vomiting, diarrhea) compared to higher doses, with tolerability comparable to placebo 3, 4
- Efficacy is evident after 2 weeks and maintained throughout treatment at both doses 4
The Practical Algorithm
Step 1: Start meloxicam 7.5 mg once daily
- Assess response at 2-4 weeks
- Co-prescribe a proton pump inhibitor (choose lowest cost option) 1
- Monitor for GI symptoms, blood pressure changes, and renal function
Step 2: If pain relief is insufficient after 2-4 weeks:
- Escalate to meloxicam 15 mg once daily
- Continue PPI prophylaxis
- Reassess efficacy at 2 weeks
Step 3: If 15 mg is still inadequate:
- Consider adding opioid analgesics or switching to alternative NSAID
- Evaluate for intra-articular corticosteroid injections if moderate-to-severe pain persists 1
Critical Safety Considerations
Risk Factors That Demand Extra Caution
Before prescribing any dose, assess for:
- Age (elderly at higher risk for all NSAID toxicities)
- GI bleeding history or active ulcers (consider COX-2 inhibitor instead)
- Cardiovascular disease (all NSAIDs carry CV risk)
- Chronic kidney disease (NSAIDs can worsen renal function)
- Concurrent low-dose aspirin use (increases GI bleeding risk) 1, 5
Common Pitfall to Avoid
Don't skip the stepwise approach. Starting at 15 mg unnecessarily exposes patients to higher toxicity risk when 7.5 mg may provide adequate relief. The MELISSA study of over 9,000 patients showed meloxicam 7.5 mg caused statistically less GI toxicity than diclofenac 100 mg while providing equivalent pain reduction 3.
Context Within the Treatment Hierarchy
Remember that meloxicam should only be initiated after paracetamol (acetaminophen) and/or topical NSAIDs have proven insufficient for knee and hand osteoarthritis 1, 5. The core non-pharmacological treatments (exercise, weight loss if overweight, activity modification) should already be in place 1, 6.
Duration Matters
Use meloxicam for the shortest possible period needed to control symptoms. One study demonstrated safe use of 7.5 mg for 28 days with high GI tolerability 7, but chronic continuous use increases cumulative toxicity risk across all organ systems.